PTITF yields 4.06% · JNJ yields 2.14%● Live data
📍 PTITF pulled ahead of the other in Year 1
Combined, PTITF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PTITF + JNJ for your $10,000?
PT Indosat Ooredoo Hutchison Tbk, together with its subsidiaries, provides telecommunication services in Indonesia. The company offers post-paid and prepaid products that include various data and mobile voice solutions on 2G, 3G, and 4G broadband cellular networks under the IM3 Ooredoo brand. It also provides international calls, international roaming, and fixed line services. In addition, the company offers IoT and M2M solutions; IT services through private data center and disaster recovery center; Internet connectivity and data communication services for corporate customers; satellite-based services, such as transponder leasing, VSAT services, and TV channels for TV; cloud-based service for business transformation; and voice services. It provides services under the Ooredoo brand name. The company was founded in 1967 and is based in Jakarta, Indonesia. PT Indosat Ooredoo Hutchison Tbk (IDX:ISAT) operates as a subsidiary of Ooredoo Hutchison Asia Pte. Ltd.
Full PTITF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.